NeuBase: Fiscal Q3 Earnings Snapshot

August 11, 2022 GMT

PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $8.5 million in its fiscal third quarter.

On a per-share basis, the Pittsburgh-based company said it had a loss of 26 cents.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NBSE at